Found 100 matching trials
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma NA This study is a prospective, single-arm, phase II exploratory clinical tria...
Show More Location
The Second Qilu Hospital of Shandong University
Learn More & Join Trial
Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC PHASE2 Malnutrition is highly prevalent in patients with upper gastrointestinal tu...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer PHASE2 This study will evaluate the surgical safety and feasibility of atezolizuma...
Show More Location
City of Hope Cancer Center
Learn More & Join Trial
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009) PHASE3 The goal of this study is to learn if people who receive intismeran autogen...
Show More Location
Banner MD Anderson Cancer Center ( Site 0181)
Learn More & Join Trial
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer PHASE2 The study is intended to assess the safety and efficacy of perioperative tr...
Show More Learn More & Join Trial
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT) PHASE3 This study is a randomized, active-controlled, open-label clinical trial fo...
Show More Location
Multiple Locations
Learn More & Join Trial
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) PHASE2 The main goals are after treatment given before surgery, to measure the num...
Show More Location
Southern Cancer Center (SCC) ( Site 8004)
Learn More & Join Trial
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC PHASE2 This is a prospective, multicenter, randomized, uncontrolled Phase II study...
Show More Location
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I) PHASE3 A prospective, randomized, open-label, multicenter Phase 3 trial designed t...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer PHASE2 Previous studies have suggested that immunotherapy combined with chemothera...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial